Levofloxacin and ciprofloxacin decrease procainamide and N-acetylprocainamide renal clearances

被引：20
|
作者：
Bauer, LA
Black, DJ
Lill, JS
Garrison, J
Raisys, VA
Hooton, TM
机构：
[1] Univ Washington, Dept Pharm, Seattle, WA 98195 USA
[2] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA
[3] Univ Washington, Dept Pharm Serv, Seattle, WA 98195 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 04期
关键词：
D O I：
10.1128/AAC.49.4.1649-1651.2005
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Ten healthy adults participated in a randomized, crossover drug interaction study testing procainamide only, procainamide plus levofloxacin, and procainamide plus ciprofloxacin. During levofloxacin therapy, most procainamide and N-acetylprocainamide (NAPA) pharmacokinetic parameters, including decreased renal clearances and renal clearance/creatinine clearance ratios, changed (P < 0.05). During ciprofloxacin treatment, only procainamide and NAPA renal clearances decreased significantly.
引用
收藏
页码：1649 / 1651
页数：3
相关论文
共 50 条
  • [41] ACCUMULATION OF N-ACETYLPROCAINAMIDE (NAPA), AN ACTIVE METABOLITE OF PROCAINAMIDE (PA), IN PATIENTS WITH POOR RENAL-FUNCTION
    DRAYER, DE
    LOWENTHAL, DT
    WOOSLEY, RL
    NIES, AS
    SCHWARTZ, A
    REIDENBERG, MM
    KIDNEY INTERNATIONAL, 1976, 10 (06) : 497 - 497
  • [42] PHARMACOKINETIC STUDIES OF PROCAINAMIDE (PA) AND N-ACETYLPROCAINAMIDE (NAPA) IN HEALTHY-SUBJECTS
    WIERZCHOWIECKI, M
    MICHALOWSKA, D
    LOWICKI, Z
    OCHOTNY, R
    GRZESKOWIAK, A
    TOMASZKIEWICZ, T
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1980, 18 (06) : 272 - 276
  • [43] SIGNIFICANCE OF SIMULTANEOUS MONITORING OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE LEVELS IN BLOOD AS A THERAPEUTIC GUIDE
    SHUDO, I
    UCHIYAMA, Y
    SHIMAMURA, K
    KOIKE, Y
    MASUMOTO, Y
    JAPANESE JOURNAL OF PHARMACOLOGY, 1978, 28 : P91 - P91
  • [44] RATE OF FORMATION AND TISSUE DISTRIBUTION OF N-ACETYLPROCAINAMIDE FOLLOWING ADMINISTRATION OF PROCAINAMIDE TO RATS
    GROVE, K
    SCHNECK, DW
    PHARMACOLOGIST, 1976, 18 (02): : 161 - 161
  • [45] CLASS-I ANTIARRHYTHMIC AGENTS - QUINIDINE, PROCAINAMIDE AND N-ACETYLPROCAINAMIDE, DISOPYRAMIDE
    RODEN, DM
    WOOSLEY, RL
    PHARMACOLOGY & THERAPEUTICS, 1983, 23 (02) : 179 - 191
  • [46] EFFECTS OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE ON MYOCARDIAL-CONTRACTILITY IN ISCHEMIC ISOLATED HEARTS
    KLUGER, J
    HORNER, WH
    REIDENBERG, MM
    CLINICAL RESEARCH, 1979, 27 (03): : A565 - A565
  • [47] REMISSION OF PROCAINAMIDE-INDUCED LUPUS-ERYTHEMATOSUS WITH N-ACETYLPROCAINAMIDE THERAPY
    STEC, GP
    LERTORA, JJL
    ATKINSON, AJ
    NEVIN, MJ
    KUSHNER, W
    JONES, C
    SCHMID, FR
    ASKENAZI, J
    ANNALS OF INTERNAL MEDICINE, 1979, 90 (05) : 799 - 801
  • [48] DETERMINATION OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    STEARNS, FM
    BROUSSARD, LA
    EARLY, RJ
    SHAW, LM
    SPRATT, B
    FRINGS, CS
    CLINICAL CHEMISTRY, 1981, 27 (12) : 2064 - 2067
  • [49] EVALUATION OF 3 DIFFERENT METHODS FOR THE DETERMINATION OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE SERUM LEVELS IN PATIENTS WITH RENAL-DISEASE
    KIANG, W
    HU, HY
    SMITH, C
    CLINICAL CHEMISTRY, 1984, 30 (06) : 1018 - 1019
  • [50] EFFECT OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE ON ATRIAL-FLUTTER - STUDIES INVIVO AND INVITRO
    WU, KM
    HOFFMAN, BF
    CIRCULATION, 1987, 76 (06) : 1397 - 1408
12345